The review, authored by Yuefan Zhang, Yan Zhang, Shuo Xia, Aamer Ali Shah, Rui Zhang and corresponding author Chunjie Gong of Hubei University of Technology and collaborating institutions, arrives at a moment when demand for xylitol is climbing alongside the global rise in diabetes. Unlike sucrose, xylitol delivers sweetness with a low glycemic impact, and decades of research have linked it to benefits ranging from cavity prevention to possible roles in respiratory health, skin barrier function and gut microbiome modulation. But producing it at industrial scale remains expensive, and the new analysis argues that the answer lies not in better chemistry but in smarter biology.

At the heart of the biological route is a single enzymatic step. Xylose, a five-carbon sugar abundant in hemicellulose from agricultural waste such as corncobs, sugarcane bagasse, wheat straw and rice straw, is reduced to xylitol by the enzyme xylose reductase. In nature, yeasts such as Candida tropicalis, Candida guilliermondii, Debaryomyces hansenii and Yarrowia lipolytica perform this conversion, and bacteria including Enterobacter species and engineered Escherichia coli can be coaxed to do the same. The catch is that the reaction consumes reduced nicotinamide cofactors, NADH or NADPH, which the cell must continuously regenerate. When cofactor supply runs dry, production stalls, and unwanted byproducts accumulate as the microbe reroutes carbon elsewhere.

This cofactor bottleneck is precisely where modern metabolic engineering has made its mark. The review details how researchers have rebuilt xylitol pathways from the ground up: overexpressing xylose reductase, deleting xylitol dehydrogenase so the product cannot be consumed again, and rewiring the pentose phosphate pathway to pump out the NADPH the reductase demands. In engineered E. coli, teams have multiplied copies of the xylose reductase gene while deleting genes of the Embden-Meyerhof-Parnas glycolytic route, forcing carbon flux toward NADPH regeneration and sharply improving yields. Similar logic has been applied in yeasts, where co-expression of pentose phosphate pathway genes in Candida tropicalis boosted xylitol titers, and disruption of the xylitol dehydrogenase gene under fully aerobic conditions raised both productivity and yield.

Beyond single-gene interventions, the field has embraced modular design. Rather than tweaking one enzyme at a time, synthetic biologists now assemble pathway modules that can be independently tuned, balancing expression strengths through choices of promoters and ribosome binding sites. Dynamic control systems add another layer of sophistication: in engineered E. coli, researchers have placed feedback regulatory loops under programmable control, improving NADPH flux and xylitol biosynthesis simultaneously. Cofactor engineering has even extended to redesigning the coenzyme specificity of central metabolic enzymes, a strategy proven in other products and increasingly relevant to xylitol, where the balance between NADH and NADPH dictates how much reducing power is available for the key reductive step.

Choice of host organism matters as much as pathway design. The review weighs the trade-offs among industrial chassis cells: natural xylose-fermenting yeasts like Candida and Debaryomyces species are robust on lignocellulosic hydrolysates but may not be food-grade; the baker’s yeast Saccharomyces cerevisiae is Generally Recognized As Safe and genetically tractable but needs extensive engineering to consume xylose efficiently; E. coli grows fast and tolerates manipulation but raises regulatory hurdles for food applications. Thermotolerant hosts such as Kluyveromyces marxianus offer the bonus of high-temperature fermentation, cutting cooling costs, while oleaginous yeasts like Yarrowia lipolytica can co-consume crude glycerol and xylose, turning two waste streams into one product. Even filamentous fungi have entered the arena, with engineered Neurospora crassa producing xylitol from xylose and Aspergillus niger converting L-arabinose into the sweetener.

Feedstock strategy is evolving in parallel. Hemicellulosic hydrolysates from corncob, sugarcane bagasse, wheat straw, rapeseed straw and even banana peel provide cheap xylose, but they carry inhibitors, furans and acids, that poison fermentation, requiring detoxification steps. Recent work has explored co-substrate models that pair xylose with other sugars to sustain cofactor regeneration, and a striking new mode uses the microalga Chlorella sorokiniana driven synergistically by light and co-substrates to biosynthesize xylitol, hinting at photosynthesis-assisted production. Adaptive laboratory evolution, in which strains are bred for tolerance to hydrolysate toxins over many generations, rounds out the toolkit for making industrial feedstocks usable.

The most forward-looking section of the review concerns artificial intelligence. Machine learning models, from artificial neural networks and support vector regression to deep neural networks, are already predicting fermentation outcomes and optimizing bioreactor parameters, with early demonstrations coupling neural networks to genetic algorithms to maximize xylitol production by Debaryomyces nepalensis. Protein language models and structure-prediction systems of the AlphaFold era now allow researchers to forecast enzyme properties and steer directed evolution of xylose reductases toward higher activity and better cofactor preference, while deep learning tools navigate biosynthetic pathways for natural products. Genome-scale metabolic models fused with machine learning can characterize cell growth from multi-omics data, and multimodal networks promise to integrate fermentation time-courses with transcriptomic and flux information into unified predictive frameworks.

All of this feeds into what the authors describe as a closed-loop design-build-test-learn cycle. In this framework, AI predicts metabolic network behavior and proposes enzyme variants; automated construction builds the strains; high-throughput testing measures performance; and the results are fed back to refine the models. Computational fluid dynamics and process modeling extend the loop from the cell to the bioreactor, while techno-economic and sustainability analyses, including assessments of xylitol production within integrated biorefinery platforms aimed at circular economies, evaluate whether bio-xylitol can compete with petrochemical and catalytic hydrogenation routes on cost and carbon footprint.

The review is candid about remaining obstacles: enzymatic bottlenecks, carbon flux imbalances, feedstock variability, downstream purification costs and the regulatory demands of food-grade production all persist. It also notes that the health conversation around xylitol is not settled, with recent research reporting potential prothrombotic associations that warrant attention even as dental and metabolic benefits remain well documented. Still, the authors conclude that the convergence of rational metabolic engineering, food-grade chassis optimization and AI-guided bioprocessing provides a comprehensive blueprint for making microbial xylitol economically viable. If the design-build-test-learn loop matures as its proponents hope, the sweetener in sugar-free gum and diabetic-friendly foods may soon come from fermentation tanks where algorithms, not just chemists, decide what the microbes make next.

Subject of Research: Metabolic engineering and AI-driven bioprocessing of microbial cell factories for xylitol production

Article Title: Advances in microbial cell factories for substitute sugar xylitol production: from metabolic engineering to AI-driven bioprocessing

Article References: Zhang, Y., Zhang, Y., Xia, S., Shah, A. A., Zhang, R., & Gong, C. (2026). Advances in microbial cell factories for substitute sugar xylitol production: from metabolic engineering to AI-driven bioprocessing. 3 Biotech, 16(10), Article 427. https://doi.org/10.1007/s13205-026-05072-8

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05072-8

Keywords: xylitol, metabolic engineering, microbial cell factories, xylose reductase, cofactor engineering, synthetic biology, artificial intelligence, bioprocessing, lignocellulosic biomass, sugar substitute, pentose phosphate pathway, industrial biotechnology